Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Cole

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group reportPeter D Cole, Cindy L Schwartz, Richard A Drachtman, et al.
Leukemia & Lymphoma|October 24, 2019
Pediatric hodgkin lymphoma: disparities in survival by raceKarishma Khullar, Zorimar Rivera-Núñez, Sachin R Jhawar, et al.
Molecular Cancer Therapeutics|November 21, 2007
Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cellsRobert C Cho, Peter D Cole, Kyoung-Jin Sohn, et al.
Pediatric Hematology and Oncology|June 25, 2002
Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicityRichard A Drachtman, Peter D Cole, Carla B Golden, et al.
Pediatric Blood & Cancer|December 10, 2021
Provider and staff crisis well-being associated with trust in leadership and baseline burnoutScott Moerdler, Dara M Steinberg, Zhezhen Jin, et al.
Pediatric Hematology and Oncology|September 25, 2010
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group reportPeter D Cole, Kathleen M McCarten, Richard A Drachtman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficitsPeter D Cole, Veena Vijayanathan, Nafeeza F Ali, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2016
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemiaStephen A Sands, Brian T Harel, Mirko Savone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Phase II trial of oral aminopterin for adults and children with refractory acute leukemiaPeter D Cole, Richard A Drachtman, Angela K Smith, et al.
Journal of Pediatric Hematology/Oncology|May 18, 2021
Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term OutcomeDana Egan-Sherry, Roma Bhuta, Peter D Cole, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group reportPeter D Cole, Cindy L Schwartz, Richard A Drachtman, et al.
Leukemia & Lymphoma|October 24, 2019
Pediatric hodgkin lymphoma: disparities in survival by raceKarishma Khullar, Zorimar Rivera-Núñez, Sachin R Jhawar, et al.
Molecular Cancer Therapeutics|November 21, 2007
Effects of folate and folylpolyglutamyl synthase modulation on chemosensitivity of breast cancer cellsRobert C Cho, Peter D Cole, Kyoung-Jin Sohn, et al.
Pediatric Hematology and Oncology|June 25, 2002
Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicityRichard A Drachtman, Peter D Cole, Carla B Golden, et al.
Pediatric Blood & Cancer|December 10, 2021
Provider and staff crisis well-being associated with trust in leadership and baseline burnoutScott Moerdler, Dara M Steinberg, Zhezhen Jin, et al.
Pediatric Hematology and Oncology|September 25, 2010
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group reportPeter D Cole, Kathleen M McCarten, Richard A Drachtman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficitsPeter D Cole, Veena Vijayanathan, Nafeeza F Ali, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 12, 2016
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemiaStephen A Sands, Brian T Harel, Mirko Savone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Phase II trial of oral aminopterin for adults and children with refractory acute leukemiaPeter D Cole, Richard A Drachtman, Angela K Smith, et al.
Journal of Pediatric Hematology/Oncology|May 18, 2021
Severe Vincristine-related Neurotoxicity in 5 Patients With Pediatric Acute Lymphoblastic Leukemia Requiring Discontinuation of Vincristine: A Description of Long-term OutcomeDana Egan-Sherry, Roma Bhuta, Peter D Cole, et al.
Pageof 11